Monday, August 17, 2026 SourcesAbout🌓
🇺🇸 US ▾
BREAKING
Billboard Hot 100 Top 10 Countdown for Aug. 22, 2026 | Billboard News Dominion still has pending lawsuits against election deniers such as Rudy Giuliani and Sidney Powell Russia is 'going backwards' in equipment and deploying post WWII-era tanks, according to Western officials Podcast: One country musician is calling for other artists to oppose assault rifles Bidets save you money and reduce waste — we tested the best options out there 50+ products to make your life easier and our planet cleaner Mother's Day is around the corner. Here are 50+ thoughtful gifts she'll love A head-to-toe guide of how men should dress this spring, and where they should shop 42 of the most useful travel products you can buy on Amazon The 7 best high-yield savings accounts of April 2023 Billboard Hot 100 Top 10 Countdown for Aug. 22, 2026 | Billboard News Dominion still has pending lawsuits against election deniers such as Rudy Giuliani and Sidney Powell Russia is 'going backwards' in equipment and deploying post WWII-era tanks, according to Western officials Podcast: One country musician is calling for other artists to oppose assault rifles Bidets save you money and reduce waste — we tested the best options out there 50+ products to make your life easier and our planet cleaner Mother's Day is around the corner. Here are 50+ thoughtful gifts she'll love A head-to-toe guide of how men should dress this spring, and where they should shop 42 of the most useful travel products you can buy on Amazon The 7 best high-yield savings accounts of April 2023
Latest

How One Woman With a Very Rare Disease Secured a Clinical Trial

The New York Times ·
How One Woman With a Very Rare Disease Secured a Clinical Trial

Through sheer determination, Neena Nizar has become the first patient in a clinical trial testing a treatment for her disease — one so rare it affects just 30 people worldwide.

Read the full article on The New York Times ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.nytimes.com — the content belongs to The New York Times.

More from The New York Times

See all ›

More in Latest

See all ›